It has been estimated that genital human papillomavirus (HPV) is the most common sexually
transmitted infection in the US. Nononcogenic types, such as HPV type 6 (HPV‐6) and HPV …

Two vaccines against HPV are commercially available: an HPV-16/18 (bivalent) and an HPV-
6/11/16/18 (quadrivalent) vaccine. Vaccination programs have been and will be …

Human papillomavirus (HPV) infection is the most common sexually transmitted infection in
the United States. Modeling estimates suggest that more than 80% of sexually active women …

The lifetime risk of human papillomavirus (HPV) infection exceeds 50%. HPV infection
causes> 550,000 cases of cervical and anogenital cancer worldwide annually. Infection also …

Human papillomavirus (HPV) is one of the most common sexually transmitted diseases
(STDs) and is frequently presented clinically as anogenital warts in both males and females …

Clinical and subclinical human papillomavirus (HPV) infections are the most common
sexually transmitted infections in the world, and most sexually-active individuals are likely to …

Background The impact of the prophylactic vaccine against human papillomavirus (HPV)
types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital disease was …

Human papilloma virus (HPV) infections, which are common, produce epithelial lesions of
the nongenital and genital skin and mucous membranes. Although most infections are …

Human papillomavirus (HPV) is the most common sexually transmitted infection in the
United States, and persistent HPV infection is strongly associated with risk of cervical cancer …

Human papillomavirus (HPV) is an extremely prevalent sexually transmitted infection that is
typically acquired soon after onset of sexual activity. The burden of HPV-related malignant …